Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 3 |
2022 | 2 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
The Upper Respiratory Tract of Felids Is Highly Susceptible to SARS-CoV-2 Infection.
Int J Mol Sci. 2021 Sep 30;22(19):10636. doi: 10.3390/ijms221910636.
Int J Mol Sci. 2021.
PMID: 34638978
Free PMC article.
Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization.
Lapuente D, Fuchs J, Willar J, Vieira Antão A, Eberlein V, Uhlig N, Issmail L, Schmidt A, Oltmanns F, Peter AS, Mueller-Schmucker S, Irrgang P, Fraedrich K, Cara A, Hoffmann M, Pöhlmann S, Ensser A, Pertl C, Willert T, Thirion C, Grunwald T, Überla K, Tenbusch M.
Lapuente D, et al.
Nat Commun. 2021 Nov 26;12(1):6871. doi: 10.1038/s41467-021-27063-4.
Nat Commun. 2021.
PMID: 34836955
Free PMC article.
Item in Clipboard
No evidence for increased cell entry or antibody evasion by Delta sublineage AY.4.2.
Arora P, Kempf A, Nehlmeier I, Graichen L, Winkler MS, Lier M, Schulz S, Jäck HM, Pöhlmann S, Hoffmann M.
Arora P, et al.
Cell Mol Immunol. 2022 Mar;19(3):449-452. doi: 10.1038/s41423-021-00811-8. Epub 2022 Jan 5.
Cell Mol Immunol. 2022.
PMID: 34983951
Free PMC article.
Item in Clipboard
The SARS-CoV-2 Delta-Omicron Recombinant Lineage (XD) Exhibits Immune-Escape Properties Similar to the Omicron (BA.1) Variant.
Arora P, Zhang L, Rocha C, Graichen L, Nehlmeier I, Kempf A, Cossmann A, Ramos GM, Baier E, Tampe B, Moerer O, Dickel S, Winkler MS, Behrens GMN, Pöhlmann S, Hoffmann M.
Arora P, et al.
Int J Mol Sci. 2022 Nov 14;23(22):14057. doi: 10.3390/ijms232214057.
Int J Mol Sci. 2022.
PMID: 36430535
Free PMC article.
Item in Clipboard
The spike protein of SARS-CoV-2 variant A.30 is heavily mutated and evades vaccine-induced antibodies with high efficiency.
Arora P, Rocha C, Kempf A, Nehlmeier I, Graichen L, Winkler MS, Lier M, Schulz S, Jäck HM, Cossmann A, Stankov MV, Behrens GMN, Pöhlmann S, Hoffmann M.
Arora P, et al.
Cell Mol Immunol. 2021 Dec;18(12):2673-2675. doi: 10.1038/s41423-021-00779-5. Epub 2021 Oct 25.
Cell Mol Immunol. 2021.
PMID: 34697413
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite